| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/10/2009 | CN101450213A Soyabean protein medicine gel and preparation method thereof |
| 06/10/2009 | CN101450212A Solid pharmaceutical dispersions with enhanced bioavailability |
| 06/10/2009 | CN100497389C Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| 06/10/2009 | CN100497387C Chimeric proteins for cell targeting and apoptosis induction and methods of using same |
| 06/10/2009 | CN100497379C Protein complex serving as vehicle for orally administerable medicaments |
| 06/10/2009 | CN100497171C Low water uptake silicas |
| 06/10/2009 | CN100496621C Methods and devices for the treatment of intervertebral discs |
| 06/10/2009 | CN100496620C Medical non-crosslinked pressure-sensitive adhesive composition, process for producing medical non-crosslinked pressure-sensitive adhesive composition and medical adhesive sheet |
| 06/10/2009 | CN100496613C Magnetic target slow-release catopril and its preparing method |
| 06/10/2009 | CN100496612C Method for synthesizing lactide copolymer grafted by beta cyclodextrin |
| 06/10/2009 | CN100496611C Preparations for topical skin use and treatment |
| 06/10/2009 | CN100496610C Method for preparing sustained-release microsphere |
| 06/10/2009 | CN100496609C Stable liposome composition |
| 06/10/2009 | CN100496608C Medical aerosol formulations |
| 06/10/2009 | CN100496605C Vaccine for treatment of tubercolosis and other intracellular infections diseases and preparing process thereof |
| 06/10/2009 | CN100496509C Carbon monoxide product and its uses for treating ileus |
| 06/10/2009 | CN100496486C Hard-soluble medicine release-controlled formulation |
| 06/10/2009 | CN100496480C Personal care compositions comprising a zinc containing material in an aqueous surfactant composition |
| 06/10/2009 | CN100496472C Topical compositions and methods for treating pain |
| 06/09/2009 | US7544782 Tumour necrosis factor binding ligands |
| 06/09/2009 | US7544767 HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
| 06/09/2009 | US7544738 Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol) |
| 06/09/2009 | US7544681 with organic acids selected to reduce the side effects induced by the psychotropic drugs and/or to exert anti-proliferative activity |
| 06/09/2009 | US7544656 Long acting injectable insulin composition and methods of making and using thereof |
| 06/09/2009 | US7544655 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 06/09/2009 | US7544500 Process for the production of a reversibly inactive acidified plasmin composition |
| 06/09/2009 | US7544487 Fusion proteins containing recombinant cytotoxic RNAses |
| 06/09/2009 | US7544374 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/09/2009 | US7544370 Mixture with cellulose ethers and water; antiulcer agents |
| 06/09/2009 | US7544367 Chemical method of making a suspension, emulsion or dispersion of pyrithione particles |
| 06/09/2009 | US7544364 reduced tissue accumulation of the glycopeptide antibiotic, reduced nephrotoxicity and reduced histamine release; side effect reduction |
| 06/09/2009 | US7544363 Exhibit probiotic activity in aerobic conditions; does not contribute to the production of future generation of antibiotic resistant pathogens |
| 06/09/2009 | US7544359 Antiischemic agents; anticholesterol agents; cardiovascular disorders |
| 06/09/2009 | US7544348 Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
| 06/09/2009 | CA2441007C Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids |
| 06/09/2009 | CA2410706C Composition and applicator for topical substance delivery |
| 06/09/2009 | CA2403345C System for the controlled delivery of an active material to a dental site |
| 06/09/2009 | CA2394232C Dual-release compositions of a cyclooxygenase-2-inhibitor |
| 06/09/2009 | CA2382886C Benzamide formulation with histone deacetylase inhibitor activity |
| 06/09/2009 | CA2377167C Multilayered tablet for administration of a fixed combination of tramadol and diclofenac |
| 06/09/2009 | CA2350659C Pharmaceutical composition for modified release insulin sensitiser |
| 06/09/2009 | CA2338323C Two-piece capsule for receiving pharmaceutical preparations for powder inhalers |
| 06/09/2009 | CA2326198C Cosolvent formulations |
| 06/09/2009 | CA2276183C Pharmaceutical preparations of glutathione and methods of administration thereof |
| 06/09/2009 | CA2196184C Sustained release preparation containing metal salt of a peptide |
| 06/09/2009 | CA2155017C Vpr function and activity |
| 06/04/2009 | WO2009070380A2 Water-soluble carbon nanotube compositions for drug delivery and medical applications |
| 06/04/2009 | WO2009070199A1 Carboxymethylcellulose polyethylene glycol compositions for medical uses |
| 06/04/2009 | WO2009069959A2 A nanoparticle for separating peptide, method for preparing the same, and method for separating peptide using the same |
| 06/04/2009 | WO2009069916A1 Pharmaceutical formulation comprising hepatitis b virus neutralizing human antibody |
| 06/04/2009 | WO2009069643A1 Solid dispersion comprising 3-[5-[4-(cyclopentyloxy)- 2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6- yl)methoxy]phenyl]propionic acid or salt thereof, or composition comprising the solid dispersion |
| 06/04/2009 | WO2009069280A1 Method for producing granulated matter |
| 06/04/2009 | WO2009069139A1 Dosage form providing an ibuprofen-containing liquid fill |
| 06/04/2009 | WO2009068996A2 Conjugated beta-1,3-linked glucans |
| 06/04/2009 | WO2009068610A1 A method for producing adapalene gels |
| 06/04/2009 | WO2009067800A1 Antibodies against a cancer-associated epitope of variant nfkbib and uses thereof |
| 06/04/2009 | WO2009067734A1 Nanoemulsions |
| 06/04/2009 | WO2009054916A3 Oligomer conjugates of lidocaine and its derivatives |
| 06/04/2009 | WO2009050555A3 Formulations of organo-platinic compounds in the presence of associative polymers, products thus obtained and uses thereof |
| 06/04/2009 | WO2009047634A3 Aqueous formulations of acetaminophen for injection |
| 06/04/2009 | WO2009046446A3 Dendrimers for sustained release of compounds |
| 06/04/2009 | WO2009029801A3 Selective cytopheresis devices and related methods thereof |
| 06/04/2009 | WO2009029087A3 Superporous hydrogels |
| 06/04/2009 | WO2009024590A3 Antifungal composition |
| 06/04/2009 | WO2008147245A3 Controlled release proxodolol pharmaceutical composition |
| 06/04/2009 | WO2008141111A3 Polymers conjugated with platinum drugs |
| 06/04/2009 | WO2008141110A3 Polyglutamate conjugates and polyglutamate-amino acid conjugates having a plurality of drugs |
| 06/04/2009 | WO2008138459A3 Aqueous pharmaceutical preparation |
| 06/04/2009 | WO2008130585A3 Wireframe nanostructures |
| 06/04/2009 | WO2008094693A4 Compositions for aerosolization of highly conductive solutions |
| 06/04/2009 | WO2002026104A3 A combination of appetite controlling agents which create a synergy and produce a satiating result |
| 06/04/2009 | US20090143747 Coiled wire for the controlled release of drugs to the eye |
| 06/04/2009 | US20090143583 Transfection reagents |
| 06/04/2009 | US20090143568 Recombinant gelatins |
| 06/04/2009 | US20090143489 Preservatives For Cosmetic, Toiletry And Pharmaceutical Compositions |
| 06/04/2009 | US20090143488 Peptides imparting umami, salt, dairy and bitter flavor |
| 06/04/2009 | US20090143487 Enhanced stability of proteins immobilized on nanoparticles |
| 06/04/2009 | US20090143486 Charge reversible polymers |
| 06/04/2009 | US20090143479 Pharmaceutical compositions comprising terbinafine |
| 06/04/2009 | US20090143403 Methods for Administering Aripiprazole |
| 06/04/2009 | US20090143387 Sustained-release tablet composition |
| 06/04/2009 | US20090143348 Polysaccharide gel compositions and methods for sustained delivery of drugs |
| 06/04/2009 | US20090143322 Cell transfecting formulations of small interfering rna related compositions and methods of making and use |
| 06/04/2009 | US20090143307 Abuse-resistant amphetamine prodrugs |
| 06/04/2009 | US20090143306 Abuse-resistant amphetamine prodrugs |
| 06/04/2009 | US20090143305 Abuse-resistant amphetamine prodrugs |
| 06/04/2009 | US20090143304 Abuse-resistant amphetamine prodrugs |
| 06/04/2009 | US20090143295 Peptide-based antiacne reagents |
| 06/04/2009 | US20090143287 Tissue regeneration substrate |
| 06/04/2009 | US20090142850 test film made of water soluble two polymers, one having high molecular weight and the other having low molecular weight such as hydroxypropyl cellulose, hydroxymethyl propyl cellulose; for detecting chorionic gonadotropin, glucose, prostate specific antigen, metabolites; pesticides; or toxin; monolayer |
| 06/04/2009 | US20090142794 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 06/04/2009 | US20090142403 Organ regeneration device |
| 06/04/2009 | US20090142379 Coated Products Containing Hydrogenated Indigestible Starch Syrup as a Binding Agent |
| 06/04/2009 | US20090142378 Controlled release dosage forms |
| 06/04/2009 | US20090142361 Drug conjugate composition |
| 06/04/2009 | US20090142325 Compositions and methods for treating tumour spreading |
| 06/04/2009 | US20090142321 Opthalmic composition |
| 06/04/2009 | US20090142268 Chain-end functionalized poly(ethykene oxide) and process for the preparation of a nano-sized transition metal or metal salt using the same |
| 06/04/2009 | US20090142266 Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest |
| 06/04/2009 | DE19549852B4 Cyclosporin enthaltende Präparate Cyclosporin-containing preparations |